Dana E. Rathkopf
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research 179
- Prostate Cancer Diagnosis and Treatment 30
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism 25
- Oncology top 1%
- Cancer Treatment and Pharmacology 34
- PARP inhibition in cancer therapy 23
-
- Radiopharmaceutical Chemistry and Applications 99
-
- Hormonal and reproductive studies 21
-
- Multiple Myeloma Research and Treatments 15
- Co-authors
- Howard I. ScherPhilip W. KantoffMin Yuen TeoMichael J. MorrisDaniel C. DanilaSteven M. LarsonCelestia S. HiganoJoshi J. Alumkal
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Dana E. Rathkopf
191 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Pulmonary and Respiratory Medicine 3.8k
- Cancer Research 1.4k
- Oncology 1.7k
- Radiology, Nuclear Medicine and Imaging 1.3k
- Endocrinology, Diabetes and Metabolism 671
Countries citing papers authored by Dana E. Rathkopf
This map shows the geographic impact of Dana E. Rathkopf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana E. Rathkopf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana E. Rathkopf more than expected).
Fields of papers citing papers by Dana E. Rathkopf
This network shows the impact of papers produced by Dana E. Rathkopf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana E. Rathkopf. The network helps show where Dana E. Rathkopf may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dana E. Rathkopf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 20 | |
| 12 | 2021 | 1 | |
| 13 | First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy | 2019 | 1 |
| 14 | 2018 | 61 | |
| 15 | 2017 | 64 | |
| 16 | 2017 | 71 | |
| 17 | 2016 | 22 | |
| 18 | 2016 | 1 | |
| 19 | 2015 | 39 | |
| 20 | Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 studybreakdown → | 2010 | 809 |
About Dana E. Rathkopf
Dana E. Rathkopf is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 203 papers that have together received 5.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (179 papers), Radiopharmaceutical Chemistry and Applications (99 papers), Cancer Treatment and Pharmacology (34 papers), Prostate Cancer Diagnosis and Treatment (30 papers), Cancer, Lipids, and Metabolism (25 papers), PARP inhibition in cancer therapy (23 papers), Hormonal and reproductive studies (21 papers) and Multiple Myeloma Research and Treatments (15 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.8k citations), Cancer Research (1.4k citations) and Oncology (1.7k citations). Dana E. Rathkopf has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Howard I. Scher, Philip W. Kantoff, Min Yuen Teo, Michael J. Morris, Daniel C. Danila, Steven M. Larson, Celestia S. Higano, Joshi J. Alumkal, Charles J. Ryan and Martin Fleisher. Their work appears in journals such as The Lancet, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.